Home/Smart Money/REGENERON PHARMACEUTICALS, INC.
§ 13F · FUND PROFILE

REGENERON PHARMACEUTICALS, INC..

AUM · $177M (13F)Positions · 3Turnover · n/a · Q2Filed · Aug 7, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$115M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 7, 2026
#TickerNameShares$ value% portΔ Q2
1PBLSParabilis Medicines, Inc.4.17M$114M64.4%NEW
2NTLAIntellia Therapeutics, Inc.3.70M$63M35.4%±0%
3ACETAdicet Bio, Inc.61K$523K0.3%NEW
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE REGENERON SIGNAL

AC read

REGENERON PHARMACEUTICALS, INC. is a Other fund managing $177 million in assets. The fund runs a focused portfolio of just 3 positions.

Read the full dossier →